Vestibular Infant Screening (VIS)–Flanders : results after 1.5 years of vestibular screening in hearing-impaired children by Martens, Sarie et al.
1
Vol.:(0123456789)
Scientific Reports |        (2020) 10:21011  | https://doi.org/10.1038/s41598-020-78049-z
www.nature.com/scientificreports
Vestibular Infant Screening 
(VIS)–Flanders: results 
after 1.5 years of vestibular 
screening in hearing‑impaired 
children
Sarie Martens1*, Ingeborg Dhooge2,3, Cleo Dhondt3, Saartje Vanaudenaerde2, 
Marieke Sucaet1, Lotte Rombaut2, An Boudewyns4, Christian Desloovere5, 
Sebastien Janssens de Varebeke6, Anne‑Sophie Vinck7, Robby Vanspauwen8, 
Dominique Verschueren9, Ina Foulon10, Charlotte Staelens11, Karen Van den Broeck12, 
Claudia De Valck13, Naima Deggouj14, Nele Lemkens15, Lisa Haverbeke16, Mieke De Bock17, 
Okan Öz18, Frank Declau19, Benoit Devroede20, Christoph Verhoye21 & Leen Maes1,2
Due to the close anatomical relationship between the auditory and vestibular end organs, hearing‑
impaired children have a higher risk for vestibular dysfunction, which can affect their (motor) 
development. Unfortunately, vestibular dysfunction often goes unnoticed, as vestibular assessment 
in these children is not standard of care nowadays. To timely detect vestibular dysfunction, the 
Vestibular Infant Screening–Flanders (VIS–Flanders) project has implemented a basic vestibular 
screening test for hearing‑impaired infants in Flanders (Belgium) with a participation rate of 86.7% 
during the first year and a half. The cervical Vestibular Evoked Myogenic Potentials (cVEMP) test 
was applied as vestibular screening tool to map the occurrence of vestibular (mainly saccular) 
dysfunction in this population. At the age of 6 months, 184 infants were screened. No refers on 
vestibular screening were observed in infants with permanent conductive hearing loss. In infants 
with permanent sensorineural hearing loss, a cVEMP refer rate of 9.5% was observed. Failure was 
significantly more common in infants with severe‑profound compared to those with mild‑moderate 
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sensorineural hearing loss (risk ratio = 9.8). Since this is the first regional study with a large sample size 
and successful participation rate, the VIS–Flanders project aims to set an example for other regions 
worldwide.
The vestibular end organs play an essential role in the maintenance of balance control and gaze stabilisation 
during posture and  movements1. Several studies in young children with a bilateral severe vestibular dysfunc-
tion have shown a reduced balance performance and a delayed acquisition of gross motor milestones (e.g. head 
stabilisation, sitting and independent walking)1–10. Vestibular dysfunction can also influence fine motor skills, as 
well as writing, reading and learning skills, and may even hamper the cognitive and socio-emotional development 
of  children1,11–17. Timely detection of vestibular dysfunction is crucial in order to provide parental counselling 
and start adequate vestibular rehabilitation at a young  age1,18,19. Therefore, a standard vestibular assessment is 
needed in young children that are at risk for a vestibular dysfunction, such as hearing-impaired children. Because 
of the close anatomical and embryological relationship between the peripheral auditory and vestibular organs, 
it seems evident that whatever reason causes damage to the auditory structures, may also negatively affect the 
vestibular end  organs8,20. This was confirmed in a systematic review by Verbecque et al. who demonstrated a 
significantly higher occurrence of vestibular dysfunction in children with sensorineural hearing loss compared 
to normal-hearing children in all included  studies21.
Recently, there is an increasing interest among clinicians in the vestibular function of hearing-impaired chil-
dren and several researchers have proven the feasibility of vestibular testing from an early age on by adapting the 
standard test protocol to  children22–25. However, paediatric vestibular dysfunction often goes unnoticed due to 
the atypical expression of vestibular symptoms and the limited communicative abilities of young  children18,26. 
Additionally, paediatric vestibular assessment remains challenging and time-consuming, and child-friendly 
equipment and two experienced examiners are often needed. Therefore, paediatric vestibular assessment in 
clinical practice is only performed in specialized centres that have appropriate equipment, and is mostly limited 
to cochlear implant  candidates27–31 and children with a suspicion of vestibular  dysfunction32. To overcome the 
lack of vestibular assessment in young hearing-impaired children, the Vestibular Infant Screening–Flanders 
(VIS–Flanders) project has been set up in June 2018 in Flanders (Belgium) in order to give each newborn with 
a confirmed hearing loss access to a basic screening of the vestibular function by using only one vestibular 
test. This Flemish research project includes a standard vestibular screening by means of the cervical Vestibular 
Evoked Myogenic Potentials (cVEMP) test at the age of 6  months33. Although the vestibular screening by means 
of the cVEMP mainly evaluates saccular function and does not evaluate all vestibular end organs, the cVEMP is 
chosen as screening tool because this is a short, objective and child-friendly  test2,23,34,35. Several studies have also 
demonstrated a higher percentage of otolith dysfunction compared to semicircular canal dysfunction in hear-
ing-impaired children due to the closer anatomical and embryological relationship between the otolith organs 
and the  cochlea36–38. Furthermore, the results of the cVEMP strongly correlate with the motor performance 
of hearing-impaired children, as the otoliths detect linear and gravitational accelerations during translational 
 movements2,3,10. The rationale for vestibular screening at the age of 6 months is the following: (1) the hearing 
loss is confirmed in the majority of the children by that  age39, (2) gross motor milestones can already give an 
idea of the child’s vestibular  function3, and (3) most children have already developed sufficient head stabilisa-
tion due to sufficient development and control of neck musculature, which is fundamental for reliable cVEMP 
 assessment40. In addition, possible cochlear implant surgery which entails a potential risk for vestibular (mainly 
otolith)  deficits31,41–43, has not been performed  yet44. As a result, the vestibular (mainly saccular) status is known 
before some of these children will undergo cochlear implant surgery. This early screening enables a timely referral 
to limit the impact on the child’s motor  development19. The rationale of implementing this screening specifically 
for hearing-impaired children is their higher risk for vestibular dysfunction as mentioned earlier. Moreover, 
the vestibular screening could be perfectly added to the existing neonatal hearing screening programme for all 
newborns in Flanders (Belgium) (Fig. 1), which covers 96.9% of the target  population45. Infants who fail the 
hearing screening twice, are referred within the first weeks of life for a subsequent extensive auditory evaluation 
in a limited number of specialized centres (i.e. reference centres)46. Since all reference centres have auditory 
brainstem responses (ABR) equipment, which includes a cVEMP module, the implementation of the vestibular 
screening is practically feasible on a large scale. After confirmation of the hearing loss, the vestibular screening 
is scheduled at the age of 6 months in one of the reference centres (Fig. 1). So far, only one pilot study applied the 
cVEMP as a vestibular screening tool in infants in the context of the neonatal hearing screening  programme47. 
This study of Verrecchia et al. showed a good feasibility when using the cVEMP as a vestibular screening tool 
in infants. However, the latter study only included a small number of infants screened at very young age (mean 
age: 2.3 months) and included both normal-hearing and hearing-impaired infants.
The aim of this paper is to report the vestibular screening results obtained in the first cohort of hearing-
impaired infants enrolled in the VIS–Flanders programme and to increase awareness about vestibular dysfunc-
tion in these children. Therefore, this is the first study using the cVEMP as a standard vestibular screening tool 
on a large regional scale for hearing-impaired infants, regardless of their degree and type of hearing loss. These 
results will enable a more accurate and representative estimation of the occurrence of vestibular (mainly saccular) 
dysfunction in hearing-impaired infants.
Methods
Subjects. All infants with a confirmed permanent hearing loss (regardless of the laterality, degree and type 
of hearing loss) detected by the neonatal hearing screening programme were screened for a possible vestibular 
dysfunction in one of the 25 reference centres involved in the hearing screening programme. Infants with early-
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onset permanent hearing loss (before 10 months of age) (e.g. post-bacterial meningitis) were also included in the 
study. To determine the hearing loss characteristics, the results of the click-evoked ABR, high frequency tym-
panometry (1000 Hz), and transient evoked or distortion product otoacoustic emissions (OAE) were collected 
across all centres. The degree of hearing loss was categorized in accordance with the criteria of the International 
Bureau for Audiophonology. In subjects with bilateral hearing loss, the worst ear was taken into account to cat-
egorize the degree of hearing loss. The leading ethical committee of the Ghent University Hospital and all local 
ethical committees of the participating centres approved data collection of all subjects (registration number 
B670201835971). According to the Helsinki Declaration, written informed consents of parents were obtained 
before the start of the vestibular screening test.
Vestibular screening protocol. Around the age of 6  months, hearing-impaired infants were screened 
with the cVEMP test, as depicted in the previous publication of Martens et al.33. To circumvent frequently occur-
ring middle ear disorders in infants, bone-conducted stimuli (RadioEar B71W, Middelfart, Denmark) were pre-
sented at the ipsilateral  mastoid40,48. More specific, 500 Hz tone bursts were used with a rise/fall time of 1 ms and 
a 2 ms plateau time, an intensity level of 59 decibel normalized hearing level (dB nHL) (i.e. equivalent to 129 dB 
force level (FL)), and a stimulus repetition rate of 5 Hz. In all participating centres, the Neuro-Audio commercial 
device and accompanying software (Neurosoft, version 2010, Ivanovo, Russia) was used to automatically record 
and visually monitor electromyographic (EMG) background activity on a screen. The electromyographic (EMG) 
activity was measured by placing 1 ground electrode on the forehead, 1 reference (i.e. inverting) electrode on the 
sternum (i.e. between 1 and 2 cm below the sternoclavicular junction) and 2 active (i.e. noninverting) electrodes 
symmetrically on both bellies of the sternocleidomastoid (SCM) muscles. Subsequently, all participating centres 
were instructed to apply impedances of the self-adhesive electrodes below 5 kΩ and inter-electrode impedances 
below 2 kΩ before performing the vestibular screening test. The algorithm of the software automatically applied 
a pre-stimulus EMG recording of at least 20 ms to quantify the EMG background activity. Data acquisition was 
automatically accepted if the mean rectified voltage (MRV) values ranged between 80 and 250 µV and rejected 
outside this range. The EMG signals underwent amplification (5000 times) and bandpass filtering (10–1500 Hz). 
Minimum 35 and maximum 100 accepted sweeps were recommended and averaged for each trial.
One examiner operated the software, while the second examiner kept the child and the bone conductor 
in place during monaural stimulation. During the screening, the subjects were placed with the upper body 
upon a sloping pillow in supine position. Thereby, the examiner rotated and raised the head towards the con-
tralateral (non-test) side and placed the bone conductor with the index finger at the ipsilateral (test) mastoid 
without touching the helix of the auricle, while slightly supporting the head with the other hand. During each 
acquisition, special attention was paid to ensure that the bone conductor was always correctly kept in the above 
described position. At the same time, the parent provided distraction at the contralateral side with some toys or 
a  movie23,33. In this way, the child was motivated to maintain sufficient and stable SCM muscle contraction. Both 
examiners could observe the automatically EMG controlled recording on the screen in order to compare SCM 
Figure 1.  The existing neonatal hearing screening protocol in Flanders (Belgium) in addition with the 
vestibular screening protocol. Additional information about the brochures for parents: Brochure 1 = ‘Vestibular 
screening VIS–Flanders’; Brochure 2 = ‘What after the vestibular screening?’; Brochure 3 = ‘Tips and tricks 
for vestibular dysfunction’. (A)ABR (automated) auditory brainstem responses, OAE otoacoustic emissions, 
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muscle tension within and between the different trials of both sides. At least two trials were recorded on each 
side to check the reproducibility of the waveform. If more than two reproducible trials were recorded, two trials 
with comparable SCM muscle tension (i.e. preferred difference in averaged EMG levels ≤ 30 µV) were selected 
for further analysis on each side. To assure that all centres applied the same procedure and that reliable cVEMP 
results were obtained, one audiologist of the VIS–Flanders team was responsible to train and support all centres 
in performing the screening.
Referral criteria. cVEMP responses are considered as normal (i.e. pass) if at least two reproducible bipha-
sic P1-N1 waveforms are observed. Additionally, the rectified amplitude of at least one of the trials needs to 
reach the normative cut-off value of 1.3, which is based on normative data of the Ghent University Hospital 
obtained in a group of 34 healthy control subjects (mean age = 7.6 months; SD = 1.5 months). cVEMP responses 
are considered as aberrant (i.e. refer) in case of inconclusive (i.e. insufficient SCM muscle tension), abnormal (i.e. 
reproducible waveforms but rectified amplitude < 1.3 for all trials) or absent (i.e. no reproducible waveforms) 
responses.
Figure 1 offers an overview of the existing neonatal hearing screening protocol in Flanders (Belgium) in addi-
tion with the vestibular screening protocol and subsequent referral for motor assessment if needed. If a bilateral 
pass is obtained (after the first or, in case of a retest, second vestibular screening), an information brochure is 
provided and the screening results are discussed with the parents or caregivers along with the limitations of the 
screening test (i.e. only testing otolith (mainly saccular) function and the possibility of late-onset vestibular 
dysfunction). No further vestibular or motor follow-up is provided, unless parents or caregivers are concerned 
about the child’s motor development. If a unilateral or bilateral refer is observed during the first screening, a 
retest is performed before the age of 10 months (i.e. within 3 months after the first screening) in order to con-
firm the results (Fig. 1). In case there is no need for the treating otorhinolaryngologist to repeat the screening, 
as the results are reliable and it is practically not feasible to repeat the screening (e.g. due to limited time before 
cochlear implantation or a difficult home situation of the child), the results of the first screening are taken into 
account. Therefore, the results of the final screening test are reported (unless stated otherwise). Children with 
a unilateral or bilateral refer during the final screening fail the vestibular screening test. Subsequently, those 
children are referred for motor assessment to evaluate the necessity of physiotherapy (after the parents have 
received appropriate counselling and an information brochure)33.
Statistical analysis. The Statistical Package for Social Science (SPSS) software (IBM, version 26.0, Armonk, 
NY) was applied for data analysis. Descriptive statistics were used to compare the screening results among dif-
ferent groups regarding the degree, laterality and type of hearing loss. The two-tailed Fisher’s Exact test was used 
in infants with sensorineural hearing loss to evaluate the association between the screening results (i.e. bilateral 
pass, unilateral or bilateral refer), the laterality of sensorineural hearing loss (i.e. unilateral, bilateral) and the 
degree of sensorineural hearing loss (i.e. unilateral or bilateral mild-moderate, unilateral or bilateral severe-
profound). The latter associations were considered as statistically significant if p < 0.05.
Results
Subjects. From June 2018 until February 2020, vestibular screening was offered to 191 infants. Four of these 
infants were excluded from the dataset because further audiological assessment showed normal hearing. In one 
case, the parents withdrew their consent. Moreover, two additional cases were excluded as the first vestibular 
screening results were inconclusive (i.e. insufficient SCM muscle tension) and the parents refused the second 
screening test. The vestibular screening results of 184 infants (90 boys, 94 girls) were included in the analysis. 
At the moment of the first screening, the mean age of the infants was 6.8 months (standard deviation (SD): 
1.8 months). 8.7% (16/184) of these infants were rescheduled for a second vestibular screening (8 boys, 8 girls). 
During the second screening, the infants had a mean age of 9.3 months (SD: 2.2 months). None of the infants 
received cochlear implants before the first or second screening. A unilateral or bilateral permanent sensorineu-
ral hearing loss was reported in the majority of the subjects (91.8% (169/184)), whereas a unilateral or bilateral 
permanent conductive hearing loss (e.g. due to external auditory canal atresia) was less frequently found (8.2% 
(15/184)). None of the children had a mixed type of hearing loss. A congenital hearing loss was found in 98.9% 
(182/184), whereas an early-onset hearing loss (i.e. before the age of 10 months) was reported in 1.1% (2/184) of 
the subjects. Both infants had sensorineural hearing loss caused by meningitis at the respective age of 2 months 
and 4 months.
Participation rate. The Flemish infant welfare agency ‘Kind en Gezin’ reported a permanent congenital 
hearing loss (including all types of hearing loss) in 122 infants on average per year, which is based on the most 
recently available data (i.e. between 2013 and 2016)45. Consequently, the percentage of the target population 
with a congenital hearing loss subjected to the vestibular screening during the first 21 months of this project was 
estimated at 86.7% (182/210) (i.e. participation rate).
Refer rate. All infants with a permanent conductive hearing loss (n = 15) finally passed the vestibular screen-
ing test on both sides. More specifically, bilateral pass was found in 93.3% (14/15) on the first vestibular screen-
ing test, whereas 6.7% (1/15) needed a retest due to insufficient SCM muscle tension. Only infants with perma-
nent sensorineural hearing loss (i.e. congenital and early-onset) were taken into account for further analysis. 
In infants with sensorineural hearing loss (n = 169), bilateral pass was found in 90.5% (153/169) of the infants 
tested, yielding a refer rate of 9.5% (16/169). Table 1 provides an overview of the vestibular screening results in 
all infants with sensorineural hearing loss. Unilateral or bilateral abnormal or absent responses were recorded 
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in 7.7% (13/169) of the infants tested and inconclusive results were obtained in 1.8% (3/169) due to insufficient 
SCM muscle tension. An overview of the patients with a unilateral or bilateral refer at the first or second vestibu-
lar screening is provided in Table 2, including additional information about the hearing loss characteristics and 
the vestibular screening results.
Relation with the laterality and degree of sensorineural hearing loss. An overview of the later-
ality and degree of sensorineural hearing loss is given in Table 3. No significant difference could be observed 
between the refer rate of infants with a unilateral (10.5%, 6/57) or bilateral (8.9%, 10/112) hearing loss (p = 0.784). 
Unilateral absent cVEMP responses were found at the same side of the hearing loss in all six infants with a uni-
lateral hearing loss who failed the screening (Table 2). In bilaterally hearing-impaired infants with abnormal 
or absent responses, the cVEMP results were more diverse (i.e. unilateral abnormal (n = 2), unilateral absent 
(n = 2), bilateral abnormal (n = 1) and bilateral absent (n = 2)). Concerning the degree of hearing loss, the results 
Table 1.  Overview of the vestibular screening results in 169 infants with sensorineural hearing loss. *The 
treating otorhinolaryngologists and audiologists agreed on settling for only one screening, as it was impossible 
to reschedule the second vestibular screening before cochlear implantation (n = 3) or due to a problematic 
home situation (n = 1). Bilat. Bilateral, Unilat. Unilateral, N/A not applicable.














Refer (Unilat./Bilat.)—abnormal or absent
3.0% (5/169)
Refer (Unilat./Bilat.)—abnormal or absent
7.7% (13/169)Refer (Unilat./Bilat.)—abnormal or absent
4.7% (8/169)




Table 2.  Overview of all infants with sensorineural hearing loss with a unilateral or bilateral refer on the first 
or second vestibular screening (n = 19). HL hearing loss, Unilat. unilateral, Bilat. Bilateral, cCMV congenital 
cytomegalovirus, Feingold II Feingold syndrome type 2, Usher I Usher Syndrome type 1, CHARGE coloboma of 
the eyes, heart defects, choanal atresia, growth and developmental retardation, ear abnormalities and deafness, 
DFNB autosomal recessive deafness, N/A not applicable.
HL laterality HL degree Etiology 1st screening result 2nd screening result
Unilat. Profound right Aplasia n. VIII right Refer (Unilat.)—absent right Refer (Unilat.)—absent right
Bilat. Profound cCMV Refer (Unilat.)—absent right N/A
Unilat. Severe left Unknown Refer (Bilat.)—inconclusive Refer (Unilat.)—absent left
Unilat. Profound left Aplasia n. VIII left Refer (Unilat.)—absent left Refer (Unilat.)—absent left
Bilat. Profound Unknown Refer (Bilat.)—inconclusive Refer (Bilat.)—abnormal
Bilat. Profound DFNB1 Refer (Bilat.)—absent N/A
Unilat. Moderate left Meningitis Refer (Unilat.)—absent left Refer (Unilat.)—absent left
Unilat. Profound right cCMV Refer (Bilat.)—inconclusive Refer (Unilat.)—absent right
Bilat. Moderate right—profound left Unknown Refer (Unilat.)—abnormal left Refer (Unilat.)—absent left
Bilat. Mild left—profound right Feingold II Refer (Bilat.)—inconclusive Refer (Unilat.)—abnormal right
Bilat. Moderate right—profound left Meningitis Refer (Bilat.)—inconclusive Refer (Unilat.)—abnormal right
Unilat. Severe right Fetal hypoxia Refer (Unilat.)—absent right N/A
Bilat. Profound Usher I Refer (Bilat.)—absent N/A
Bilat. Profound CHARGE Refer (Bilat.)—inconclusive Refer (Bilat.)—inconclusive
Bilat. Profound DFNB35 Refer (Bilat.)—inconclusive Refer (Bilat.)—inconclusive
Bilat. Profound Unknown Refer (Bilat.)—inconclusive Refer (Bilat.)—inconclusive
Unilat. Moderate right Unknown Refer (Unilat.)—inconclusive left Pass
Bilat. Moderate DFNB3 Refer (Bilat.)—inconclusive Pass
Bilat. Profound DFNB1 Refer (Bilat.)—inconclusive Pass
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showed that a unilateral or bilateral refer occurred significantly more in infants with a unilateral or bilateral 
severe-profound hearing loss (14.7%, 15/102, 95% CI [9.1–22.9%]), compared to infants with a unilateral or 
bilateral mild-moderate hearing loss (1.5%, 1/67, 95% CI [0.3–8.0%]) (p = 0.003). Noteworthy, only one subject 
with a mild-moderate hearing loss failed the vestibular screening (Table 2). The calculated risk ratio (RR = 9.8) 
estimated that infants with a unilateral or bilateral severe-profound hearing loss have a higher chance to exhibit 
a unilateral or bilateral refer on the vestibular screening compared to infants with a unilateral or bilateral mild-
moderate hearing loss. Figure 2 displays the vestibular screening results among the different groups of infants 
according to their degree and laterality of sensorineural hearing loss.
Discussion
To our knowledge, this is the first large-scale regional study that aimed to accurately estimate the occurrence 
of vestibular (mainly saccular) dysfunction based on the cVEMP screening results of a representative group of 
hearing-impaired infants. Secondly, this study investigated whether the vestibular screening results differed 
among various hearing loss characteristics, including the type, degree and laterality.
Table 3.  Overview of the laterality and degree of sensorineural hearing loss in 169 infants. a 15 of the 63 
subjects who were classified with bilateral severe-profound hearing loss showed mild-moderate hearing loss in 
the other ear.
Hearing loss Mild-moderate Severe-profound Total (laterality)
Bilateral 29.0% (49/169) 37.3% (63/169)a 66.3% (112/169)
Unilateral 10.6% (18/169) 23.1% (39/169) 33.7% (57/169)
Total (degree) 39.6% (67/169) 60.4% (102/169)
Figure 2.  Vestibular screening results according to the degree and laterality of sensorineural hearing loss. 
cVEMP cervical Vestibular Evoked Myogenic Potentials, VIS–Flanders Vestibular Infant Screening–Flanders.
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In this study, 86.7% of the estimated target population participated to the vestibular screening. This finding 
demonstrates that it is indeed feasible to implement a vestibular screening test, covering the majority of congeni-
tally hearing-impaired infants across an entire region. Nevertheless, an estimated 13.3% of the infants probably 
missed the vestibular screening, which may be attributed to parents who declined their child’s participation, 
subjects who did not show up at several appointments, subjects who moved abroad after birth, and critically ill 
infants in which auditory and vestibular evaluations were not a number one priority during the first year of life. 
Whereas a rather high participation rate was observed in our study, Verrecchia et al. (2019) reported a participa-
tion rate of only 60% in their target group. The authors of the latter study attributed the low participation rate 
to the preoccupation of the parents with the outcome of the hearing  tests47. A number of other reasons could 
account for the different participation rate of both studies, such as the different ages of the study participants. 
Verrecchia et al. (2019) conducted the cVEMP test in younger infants (mean age: 2.3 months; SD: 1.9 months) 
compared to the VIS–Flanders project (mean age first cVEMP: 6.8 months; SD: 1.8 months). Moreover, the 
VIS–Flanders project solely focussed on infants with a confirmed hearing loss, whereas Verrecchia et al. (2019) 
also included normal-hearing infants at risk for hearing impairment. The higher participation rate in the current 
study may also be explained by the strong collaboration between the VIS–Flanders project and the meticulously 
organised neonatal hearing screening programme in Flanders, which enabled a large-scale implementation for 
the entire target population. The above mentioned differences emphasize the added value of implementing the 
cVEMP as a standard screening tool after the confirmation of the hearing loss around the age of 6 months. By 
then, parents are probably less likely to refuse the cVEMP test because some time is given first to emotionally 
process the child’s hearing loss, to start the child’s auditory rehabilitation, and to be properly informed about 
the importance of vestibular screening.
In the current study, all cVEMP refers were recorded in infants with a sensorineural hearing loss, as none 
of the infants with a permanent conductive hearing loss failed the vestibular screening. These findings were in 
accordance with the results of Sheykholesami et al.49,50, which indicated that the anatomical proximity of the 
cochlea and the vestibular end organs played a major role in the higher risk for vestibular dysfunction in sensori-
neural hearing-impaired infants. All children with a permanent conductive hearing loss in the latter study showed 
normal bone-conduction cVEMP  responses49. Therefore, it is assumed that otolith (mainly saccular) dysfunction 
is less likely to occur in children with a permanent conductive hearing loss. In infants with sensorineural hearing 
loss, a refer rate of 9.5% was found in the current study, consisting of 7.7% of infants with unilateral or bilateral 
abnormal or absent cVEMP results and 1.8% of infants with inconclusive results. The presence of vestibular 
(mainly saccular) dysfunction remained unknown in the infants with inconclusive results caused by bilateral 
insufficient SCM muscle tension. Noteworthy, these infants were also classified in the refer group, because the 
lack of sufficient head stabilisation suggests the presence of a vestibular (otolith) dysfunction or a delayed motor 
 development5. This implies that this specific group definitely needs referral for motor assessment. In contrast 
to our findings, the systematic review of Verbecque et al. reported a considerably higher percentage of deviant 
cVEMP results (i.e. 43.0% in general) on at least one side in children with sensorineural hearing  loss21. This higher 
percentage can be explained by the fact that the included study populations in this systematic review mainly 
consisted of older children, which can result in different cut-off values, delayed-onset vestibular dysfunction and 
potential post-cochlear implant  effects27,28,30,31. Moreover, most of the included studies focussed on children with 
severe-profound hearing  loss21, whereas the current study also included children with mild-moderate hearing 
loss. Nevertheless, the cVEMP refer rate of 14.7% in children with severe-profound hearing loss in the current 
study is still lower compared to the included studies by Verbecque et al.21. However, these included studies were 
conducted in specialized centres for cochlear implantation, congenital cytomegalovirus infection, and complex 
pathologies, thus, possibly included subjects with a higher risk for vestibular dysfunction. While the majority of 
the included studies applied the cVEMP with air-conduction  stimuli21, the current study used bone-conduction 
stimuli. The use of different stimuli may also explain different percentages of aberrant cVEMP results. Although 
saccular afferents predominantly project to cervical muscles, bone-conduction and air-conduction cVEMP tests 
stimulate the saccular macula with different  modalities51–53. In other words, the mechanisms of activating oto-
lithic receptors by air-conduction and bone-conduction stimuli are dissimilar but the exact mechanisms are 
still being  investigated54–56.Moreover, the VIS–Flanders project is the first to offer the vestibular screening to all 
hearing-impaired infants in an entire region, which enables a more representative estimation of aberrant cVEMP 
results in the overall population of young hearing-impaired children. Recently, the above mentioned study of 
Verrecchia et al. showed a higher cVEMP abnormality rate of 36.4% in their small subgroup with a sensorineural 
hearing loss compared to our refer rate of 9.5%47. As already mentioned, this study also focussed on a different 
target population, including both normal-hearing and hearing-impaired infants. Moreover, the already discussed 
lower participation rate in this study may imply that parents, who were concerned about vestibular or motor 
deficiencies in their child, were more likely to participate, which may possibly lead to a higher percentage of 
vestibular (mainly saccular) dysfunction in the study  sample57.
Regarding the relation with the laterality of hearing loss, the current study could not reveal a significantly 
different cVEMP refer rate in the group with a unilateral and bilateral sensorineural hearing loss, thereby high-
lighting the necessity of vestibular assessment even in infants with only unilateral hearing loss. These research 
findings are consistent with previous studies that also detected vestibular dysfunction in children with unilateral 
sensorineural hearing  loss58,59. Concerning the relation with the degree of hearing loss, a significantly higher 
cVEMP refer rate occurred in infants with severe-profound compared to mild-moderate sensorineural hear-
ing loss in the current study. In line with these results, Verbecque et al. reported higher percentages of deviant 
cVEMP results in more severely hearing-impaired children across  literature21, which can be directly related to 
the close anatomical and embryological relationship of the cochlea and the otolith  organs21,36,37.
The first limitation of this vestibular screening protocol is the use of only the cVEMP. As a result, the periph-
eral vestibular system is not completely evaluated, which may lead to an underestimation of the overall vestibular 
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dysfunction in this population. The second limitation is that the vestibular function is screened only once at 
the age of 6 months, and in some cases twice if a retest is needed within 3 months. Therefore, children with a 
progressive or delayed-onset hearing or vestibular deficit will be missed as well. In spite of these two limitations, 
the VIS–Flanders project makes it possible to offer a basic vestibular screening to hearing-impaired infants on 
a large scale, as the cVEMP test is a short, objective and child-friendly test of which the equipment is widely 
 available33. As longitudinal and extensive vestibular assessment is currently not feasible on a large scale in clinical 
practice, the vestibular screening at least ensures an early identification of vestibular (mainly saccular) dysfunc-
tion and subsequent motor referral if needed. Furthermore, the VIS–Flanders project increases awareness among 
parents and caregivers on vestibular dysfunction in hearing-impaired children, and provides information about 
the limitations of the screening test and the importance of an extensive vestibular assessment if necessary. In 
the future, it is aimed to more precisely map the predictive factors for vestibular dysfunction, such as the etiol-
ogy of hearing loss, in a larger sample size of hearing-impaired infants in order to set guidelines to refine the 
vestibular screening protocol.
Conclusion
The VIS–Flanders project is the first in its kind to implement a standard vestibular screening by means of the 
cVEMP test for hearing-impaired infants in an entire region. This study showed a 9.5% vestibular screening 
refer in a representative population of infants with unilateral or bilateral sensorineural hearing loss. This study 
also showed that the implementation of a vestibular screening programme is feasible, since a participation rate 
of 86.7% was achieved. In line with previous studies, a significantly higher proportion of infants with unilateral 
or bilateral severe-profound sensorineural hearing loss failed the vestibular screening compared to those with 
unilateral or bilateral mild-moderate sensorineural hearing loss (RR = 9.8). Besides the degree of hearing loss, 
future studies also need to focus on the underlying etiology of hearing loss in order to more precisely map the 
predictive factors for vestibular dysfunction in this population and to refine the vestibular screening protocol. As 
this study clearly indicates that a standard vestibular screening in hearing-impaired infants is feasible on a large 
regional scale, the VIS–Flanders project aims to increase awareness about vestibular dysfunction in hearing-
impaired children by setting an example for other regions worldwide.
Data availability
As this study concerns a large-scale regional ongoing project and the dataset contains data of paediatric patients 
from all different participating centres, data will not be made available at this stage.
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